Otelixizumab
Product Specifications
CAS Number
881191-44-2
Target
Others|||Integrin
Related Pathways
Others|||Cytoskeletal Signaling
Purity
0.9713
Bioactivity
Otelixizumab (ChAglyCD3) is a chimeric monoclonal antibody targeting CD3, used in research on Type 1 diabetes and autoimmune diseases.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1400816-01 0.02 mg (E-Coli)
Recombinant Shewanella sp. UPF0758 protein Shewmr4_3597 (Shewmr4_3597)
Ask
View Details 
MBS1400816-02 0.1 mg (E-Coli)
Recombinant Shewanella sp. UPF0758 protein Shewmr4_3597 (Shewmr4_3597)
Ask
View Details 
MBS1400816-03 0.02 mg (Yeast)
Recombinant Shewanella sp. UPF0758 protein Shewmr4_3597 (Shewmr4_3597)
Ask
View Details MBS1400816-04 0.1 mg (Yeast)
Recombinant Shewanella sp. UPF0758 protein Shewmr4_3597 (Shewmr4_3597)
Ask
View Details 
MBS1400816-05 0.02 mg (Baculovirus)
Recombinant Shewanella sp. UPF0758 protein Shewmr4_3597 (Shewmr4_3597)
Ask
View Details